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Abstract
Background: Despite decades of efforts to improve quality of health care, poor performance persists in
many aspects of care. Less than 1% of the enormous national investment in medical research is focused on
improving health care delivery. Furthermore, when effective innovations in clinical care are discovered,
uptake of these innovations is often delayed and incomplete. In this paper, we build on the established
principle of 'positive deviance' to propose an approach to identifying practices that improve health care
quality.
Methods: We synthesize existing literature on positive deviance, describe major alternative approaches,
propose benefits and limitations of a positive deviance approach for research directed toward improving
quality of health care, and describe an application of this approach in improving hospital care for patients
with acute myocardial infarction.
Results: The positive deviance approach, as adapted for use in health care, presumes that the knowledge
about 'what works' is available in existing organizations that demonstrate consistently exceptional
performance. Steps in this approach: identify 'positive deviants,' i.e., organizations that consistently
demonstrate exceptionally high performance in the area of interest (e.g., proper medication use, timeliness
of care); study the organizations in-depth using qualitative methods to generate hypotheses about
practices that allow organizations to achieve top performance; test hypotheses statistically in larger,
representative samples of organizations; and work in partnership with key stakeholders, including potential
adopters, to disseminate the evidence about newly characterized best practices. The approach is
particularly appropriate in situations where organizations can be ranked reliably based on valid
performance measures, where there is substantial natural variation in performance within an industry,
when openness about practices to achieve exceptional performance exists, and where there is an engaged
constituency to promote uptake of discovered practices.
Conclusion: The identification and examination of health care organizations that demonstrate positive
deviance provides an opportunity to characterize and disseminate strategies for improving quality.
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Introduction
Despite decades of efforts to improve quality of health
care, poor performance persists in many aspects of care.
Patients often do not receive guideline-recommended
processes of care [1-3], and risk-adjusted outcomes vary
substantially across hospitals [4] and regions [5,6], sug-
gesting potential for improvements. Furthermore, despite
enormous national investment in biomedical research,
less than 1% of this is directed at research on improving
health care delivery [7], and when innovations in clinical
care are discovered, the uptake of these improvements
into practice is often delayed and incomplete [8-11].
We describe an approach to quality of care research that
identifies innovative strategies from 'positive deviants' in
health care, those organizations that consistently demon-
strate exceptionally high performance in an area of inter-
est (e.g., survival rates, medication use, and timely
emergency treatment). The central premise of a positive
deviance approach [12,13] is that solutions to problems
that face a community often exist within that community,
and that certain members possess wisdom that can be
generalized to improve the performance of other mem-
bers. Many of these strategies rely on resources that
already exist in the community, which can increase their
adoption and sustained use [14].
The power of a positive deviance approach to improve
health outcomes has been shown in complex problems
globally, including pregnancy outcomes [15], condom
use [16], and childhood nutrition [12,17,18]. In a dra-
matic application of positive deviance in Vietnam, child-
hood malnutrition was reduced by 75% [12]. Researchers
identified a set of women as 'positive deviants' because
their children were thriving despite high rates of child-
hood wasting and stunting in their rural villages. The
women were including in their cooking pots tiny shrimps
and crabs, found in large numbers in rice paddies but not
normally used because fish were generally thought to be
inappropriate for young children [18]. The subsequent
randomized controlled trial showed significant improve-
ments in health outcomes of children fed in this way
[12,17,19]. This method of food preparation was then dis-
seminated and sustained years after the original studies
[20]. The 'best practice' was based on proven, successful
practices within the community, rather than theoretical
concepts of good nutrition.
How might this potentially powerful approach be used to
improve quality of health care delivery in the United
States? How does it differ from other strategies of identify-
ing and disseminating best practices, and in what circum-
stances might this approach be most effective? We address
these questions in the following five sections. In the first
section, we provide an overview of the positive deviance
approach as applied to the organizational setting and dis-
cuss when its application is most useful. In the second sec-
tion, we outline core methodological considerations in
this approach. In the third section, we compare the posi-
tive deviance approach to alternative methods of identify-
ing best practices, including standard biomedical and
epidemiologic research and quality improvement and
action research. In the fourth section, we draw on theoret-
ical literature to describe how the positive deviance
approach can promote effective dissemination of best
practices. We conclude with an illustrative example of the
positive deviance approach applied to improving hospital
care nationally for patients with myocardial infarction.
Overview of positive deviance approach
The positive deviance approach accomplishes two goals:
the identification of practices that are associated with top
performance, and promoting the uptake of these practices
within an industry, using the following steps (Figure 1):
identify 'positive deviants,' i.e., organizations that consist-
ently demonstrate exceptionally high performance in the
area of interest (e.g., proper medication use, timeliness of
care); study the organizations in-depth using qualitative
methods to generate hypotheses about practices that ena-
ble organizations to achieve top performance; test
hypotheses statistically in larger, representative samples of
organizations; and work in partnership with key stake-
holders, including potential adopters, to disseminate the
evidence about newly characterized best practices.
When should one consider using a positive deviance
approach to identify and disseminate best practices in
health care organizations? First, the approach requires
concrete, widely endorsed, and accessible performance
measures for organizations. For instance, in the case of
hospital care, there are several specific, validated, and
publicly-reported performance measures; therefore, hos-
pitals can be ranked according to performance, and posi-
tive deviants within the industry can be identified. In
contrast, there are no publicly accessible data on perform-
ance measures for many health care conditions such as
treatment of children with fevers or hospital falls among
elderly, among others. Positive deviance studies in these
areas would therefore be difficult to accomplish.
Second, the positive deviance approach works when there
is variation in organizational performance and outcomes
across the industry, with some organizations achieving
marked and consistent top performance and other organ-
izations not doing so, i.e., there are positive deviants.
Additionally, the approach is effective when organiza-
tions are adequately open to sharing their strategies for
exceptional performance. In cases where organizations are
highly proprietary and resistant to sharing what might be
viewed as competitive advantages or 'trade secrets,' the
positive deviance approach is unlikely to produce mean-
ingful results.Implementation Science 2009, 4:25 http://www.implementationscience.com/content/4/1/25
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Third, the approach is effective when hypotheses gener-
ated from the experience of top performing organizations
can be tested in larger, representative samples. Evidence
from statistical testing is particularly useful when dissem-
inating findings to health care organizations because cli-
nicians, whose support is often fundamental to successful
changes in clinical processes [21,22], are more likely to
consider such evidence credible and valid.
Finally, for potential adopting organizations, the per-
ceived importance of improvement on the selected per-
formance measure can enhance effective dissemination.
Involving potential adopters in the development and test-
ing of a particular practice can also accelerate the pace and
scope of uptake by increasing the fit of the practice with
the organizational context.
Methodological considerations in the positive deviance 
approach
Sampling strategy and sample size
Studies using positive deviance begin with purposive sam-
pling, with the goal of selecting organizations based on
diversity of performance with adequate representation of
organizations with exceptional performance. As is stand-
ard in purposive sampling for qualitative studies [23], the
sample should be diverse in characteristics potentially
salient to performance, such as size, ownership type,
teaching status in the case of hospitals, and geographical
location. Ensuring adequate diversity among the top per-
forming organizations studied is critical to isolating
through several cases what might be common in achiev-
ing top performance, as well as enhancing the transfera-
bility of findings to a broad range of potential adopters.
Principles of qualitative research are used to develop the
sampling strategy [23], and the sample size at this first
stage is determined by theoretical saturation [24], i.e.,
when successive sampling does not produce additional
hypotheses.
The sampling strategy for the next stage of a positive devi-
ance study, in which one is statistically testing hypotheses
generated from the qualitative study, employs methods
for quantitative investigation. The goal is to sample the
universe of relevant organizations in order to attain a
large, representative sample of the industry to which one
is generalizing, thereby permitting valid and precise infer-
ences from subsequent statistical analysis. Sample size is
determined by considerations of statistical power and
desired level of precision.
Data collection and measurement
The in-depth examinations of organizations requires
open-ended, qualitative data collection methods that
explore both specific strategies taken by organizations as
well as the broader context in which such strategies are
employed [23,25]. A particular benefit of the positive
deviance approach is the ability to integrate organiza-
tional context (e.g., concepts of organizational culture,
norms of behavior, inter-group relations) into the under-
standing of 'what works' or best practices. This integration
is often neglected in randomized controlled trials and dif-
ficult to measure in quantitative studies. Data collection
may include observations, in-depth interviews and focus
groups with staff, archival reviews of documents from the
organization, or a combination of these methods, with
the goal of developing a deep understanding of the organ-
ization and how it functions relative to the particular per-
formance measures.
A core challenge and opportunity in positive deviance
studies is the linking of the qualitative findings (i.e.,
hypotheses) and the quantitative measures of those varia-
bles hypothesized to influence performance. A benefit of
the mixed methods approach [26], when qualitative pre-
cedes quantitative studies, is the richness of information
that can then inform the development of comprehensive
and precise quantitative measurement. At the same time,
some hypotheses may include constructs for which there
are not validated quantitative measures or for which
Steps in the positive deviance approach Figure 1
Steps in the positive deviance approach.
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quantitative measures cannot be developed. In such cases,
it is not uncommon to restrict the statistical measurement
to those hypotheses that lend themselves to quantitative
measurement, recognizing that the best practices may ulti-
mately emerge from the union of findings from both stud-
ies.
Data analysis
Data analysis should be conducted in accordance with
standard principles for qualitative and for quantitative
analysis [23,27]; however, it is of critical importance that
the 'outcome' variable is well-measured with precision
and validity, as it not only determines the initial purpose-
ful sample but also forms the bases of the outcome meas-
urement for the quantitative study. The performance
measure(s) should be well-conceived and widely
endorsed prior to the study.
Comparisons of alternative approaches
How does the positive deviance approach compare with
other approaches to identifying and disseminating best
practices? Although there are many, we focus on two alter-
native approaches to the identification of best practices,
which are commonplace in research on quality of care:
biomedical or epidemiological outcomes research, and
quality improvement [28,29] and action research [30-34].
We discuss the theoretical underpinnings of these
approaches, comparing and contrasting them to the posi-
tive deviance approach.
Biomedical or epidemiologic outcome research approaches
Biomedical or epidemiologic outcomes research focuses
on developing an evidence base through quantitative
measurement and statistical examination of a variety of
predictors or correlates of an identified outcome, i.e., a
performance measure. In health care, for instance, hierar-
chical generalized linear models [35,36] can be used to
estimate hospital-level effects from patient-level data to
isolate what might be organization-level variables (i.e.,
clinical protocols, data audit and feedback processes) that
are statistically related to an outcome (i.e., complication
rates, timeliness of care).
The advantage of this approach to identifying best prac-
tices is that the production of statistical associations is
often based on the experience of a large sample of organ-
izations and, particularly for health care, produced in a
language and with methods that are credible to physicians
whose involvement is often important for successful
adoption and implementation of best practices by a
health care organization.
Conversely, a disadvantage of this approach is that it typ-
ically neglects the complexity of organizational context,
which is problematic given that organizational factors can
be important barriers to implementation of innovative
practices or programs [37-39]. Randomized or controlled
trials standardize implementation procedures, limiting
the understanding of how real-life variation in implemen-
tation (e.g., differences in monitoring functions, reward
systems, leadership styles) might influence the impact of
various practices on the outcome. Furthermore, such stud-
ies do not delve into the variation within the intervention
or non-interventions arms of the trials to understand how
organizational context might influence the success of the
intervention. As a result, while such trials produce useful
data, they do not provide insight into organizational fea-
tures such as inter-group relations, leadership, and culture
might influence the impact of the intervention on per-
formance. Furthermore, the organizations in which such
studies are conducted may be systematically different
from most. Although this is the concern of generalizabil-
ity from any type of research, organizations that partici-
pate in randomized and controlled trials may be
particularly distinct (often large teaching or research facil-
ities) from potential adopting organizations. In summary,
such studies can provide credible statistical evidence, par-
ticularly if they are integrated in the hypothesis testing
step of positive deviance studies; however, used in isola-
tion, such studies they may oversimplify recommenda-
tions for best practices with inadequate attention to the
subtleties of implementation, thereby slowing their trans-
lation into practice and widespread uptake.
Quality improvement and action research approaches
Quality improvement and action research, as applied to
organizations, both focus on developing best practices
within focal organizations. The approaches recognize the
importance of organizational context, and the goal of
developing best practices for the selected organization.
Quality improvement [28,40] seeks to improve and/or
reduce variation in work processes to improve the organi-
zation's ability to meet its goals. Action research, as
applied to organizations, uses an iterative cycle of prob-
lem identification, planning, intervention, and evaluation
to develop innovative solutions through researcher-staff
collaboration in problem solving [30-32,41]. In both
quality improvement and action research, the emphasis is
on internal development and implementation of best
practices for that particular organization or unit within
the organization.
There are strengths to these approaches, which have been
shown to improve targeted administrative and clinical
performance measures in health care [28,42]. For exam-
ple, substantial organizational learning can arise from
quality improvement and action research projects; such
learning can ultimately improve the identified process as
well as provide staff expertise and create norms that allow
staff to subsequently improve other processes in theImplementation Science 2009, 4:25 http://www.implementationscience.com/content/4/1/25
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organization. In addition, the approaches do recognize
the importance of organizational context, building
knowledge about 'what works' within the context of the
internal organization, and potentially thereby improving
success in implementation within that organization.
However, there are also important limitations to consider.
The process of development of best practices in these
approaches is informed typically by a very small sample of
organizations, even a single organization or unit within
an organization. Particularly for action research, solutions
are developed within and for a selected organization;
these solutions may not be amenable to widespread dis-
semination, thus limiting opportunities for large-scale
change. In addition, these approaches neglect potential
extant knowledge among other organizations that have
previously attained top performance, which is not inte-
grated into the quality improvement or action research
efforts. Finally, neither quality improvement nor action
research has an explicit goal of disseminating the knowl-
edge gained to the larger community or industry.
Positive deviance approach
The positive deviance approach integrates some of the
strengths of each of these approaches by combining inten-
sive organizational-level examination using qualitative
methods with the broader-scale statistical analysis possi-
ble with a large sample of organizations. The positive
deviance approach allows for the explicit integration of
real-life implementation issues and organizational con-
text because it seeks to characterize not just what processes
and practices are present in top performing organizations
but also the context (e.g., organizational culture, leader-
ship support, norms of behavior) in which they are imple-
mented. These practices are characterized by extracting
common themes or hypotheses based on several, rather
than single, organizational settings where the proof of
concept exists. This attention to organizational context is
particularly important for complex, adaptive organiza-
tions [43] such as many health care organizations, which
have multiple objectives and authority structures, and
diverse technological underpinnings of their production
functions. Although the replication of best practices
requires sensitivity to the unique organizational context
of the adopting organization [33,34,39,44-46], the posi-
tive deviance approach characterizes important contextual
factors as part of the description of how top performers
achieved their success.
In addition to the advantage of using scientific methods
that address concerns of organizational context, the posi-
tive deviance approach also uses statistical analysis to
develop evidence that supports or refutes the many
hypotheses developed from the qualitative study. The
combination of these methods identify practical solutions
because they are by definition already implemented in
some organizations, which are also robust in that they are
supported by statistical evidence. For adopters, the pres-
ence of statistical information infers that the effectiveness
of these practices in other organizations was not just by
chance alone, but that their implementation is likely to
result in improved performance in other organizations as
well.
Despite these strengths of the positive deviance approach,
there are limitations relative to the other approaches. In
some but not all cases, positive deviance studies may rely
on self-reports of organizational practices rather than pro-
cedures of a controlled trial, which may result in reporting
bias, although established survey methods can be used to
limit measurement error [47-49]. Additionally, for some
insights found through a positive deviance approach, par-
ticularly related to organizational context (e.g., inter-
group relations, power dynamics), it may be difficult to
create valid, quantitative measures; in such cases, evidence
may come solely from qualitative studies, which may not
have credibility among certain individuals who are central
to successful uptake and implementation. Furthermore,
relative to quality improvement and action research
efforts, the positive deviance approach focuses on organi-
zations learning from external sources rather than internal
process improvement efforts. Consequently, staff mem-
bers of adopting organizations may not achieve the same
level of learning and investment as they might if they were
to develop best practices themselves. Nevertheless, even if
the practice originates from outside the focal unit or
organization, its adoption into a new organization typi-
cally requires adaptation to local circumstances in which
staff must engage and hence learn [50]. Finally, character-
izing best practices based on current performance may
limit the expansive nature of discovery to what is achieva-
ble within the bounds of current constraints and
approaches. Therefore, the positive deviance approach
should be balanced with sustained de novo discovery
efforts that periodically can fully shift the paradigm of an
industry in ways not possible through the study of only
positive deviance.
Ultimately, there are two major differences between the
positive deviance approach and a quality improvement or
action research approach. First, in positive deviance
approaches, the best practices are assumed to already
exist; they are not built de novo through a quality improve-
ment of action research cycle of inquiry. Second, the
source of best practices differs. Whereas quality improve-
ment methods seek to discover through experimentation
and data feedback within the organization, the positive
deviance approach focuses on learning from exceptional
examples of extant performance external to the focal unit
or organization.Implementation Science 2009, 4:25 http://www.implementationscience.com/content/4/1/25
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Dissemination of best practices
Promoting wide dissemination of best practices, particu-
larly among health care organizations, has been the sub-
ject of expansive theoretical inquiry [45]. A distinguishing
strength of the positive deviance approach is the focus on
active dissemination of best practices. Existing theories
[44,46,51-55] identify several factors that influence the
shape of the trajectory of diffusion, or spread, of innova-
tions throughout an industry (Figure 2): features of the
innovation, the dissemination strategy, the alignment of
the external environment with adoption of the innova-
tion, and features of the adopting organizations, or users.
The positive deviance approach to identification and dis-
semination of best practices employs some of the key fea-
tures thought to speed diffusion, or spread. First, some
theoretical literature [44,45,52,53] suggests that innova-
tions diffuse more quickly if they are perceived to provide
advantage relative to the status quo, if they are compatible
with current practices, if they are relatively simple to
understand and implement, if they can be piloted, and if
they generate observable improvements. Because data
originate with top performing organizations in the posi-
tive deviance approach, best practices are largely viewed as
providing relative advantage, being compatible with cur-
rent practice (they are in place in some organizations
already), and generating observable improvements (top
performance can be measured). Second, the theoretical
literature [45,52,53,56] also suggests the dominant mech-
anism for successful spread is interpersonal influence
through professional and social networks, as well as links
to opinion leaders. The credibility of communication
channels both external to the organization and within the
organizations are important. Critical to the positive devi-
ance approach is that the top performers are those that
have access to similar resources and come from the same
communities or industry as potential adopters, allowing
for greater interpersonal influence through existing pro-
fessional associations and social networks [52,56] and
engagement of opinions leaders, which is helpful to
encourage initial adoption and subsequent implementa-
tion by users [45,52]. Finally, the positive deviance
approach calls for the inclusion of potential adopters in
the earliest studies of 'what works.' Organizational charac-
teristics that make potentially adopting organizations and
units within organizations more likely to adopt recom-
mended changes are beyond the scope of the paper, and
have been well-documented [44-46,51-55,57]; however,
in the positive deviance approach, organizations partici-
pate closely in the research, and because the findings
reflect their knowledge and experience, sites are often
strongly motivated and receptive to implementing find-
ings. Inclusion of stakeholders in producing relevant evi-
dence for health care improvement has been shown to be
successful in large-scale organizational changes [45,57].
Using a positive deviance approach to improve care for 
acute myocardial infarction
Background
We used a positive deviance approach in our recent efforts
to improve hospital care for patients with acute myocar-
dial infarction. In the span of three years, the proportion
of patients whose care met the targeted national guide-
lines for timeliness of care for ST-segment elevation myo-
cardial infarction increased from about 50% to more than
75% of patients. The process reveals the potential of the
positive deviance approach to identifying and disseminat-
ing best practices in order to accelerate whole-system
change.
Prompt treatment is critical for survival of patients with
ST-segment elevation myocardial infarction [58-60]. The
time interval between symptom onset and hospital
arrival, and between hospital arrival and treatment with
percutaneous coronary intervention (PCI) (which can re-
establish blocked blood flow to the heart) are important
predictors of survival [59-61]. Although hospitals have
less control over the time interval from symptom onset to
hospital presentation, they have direct control over the
time interval from hospital arrival to PCI, known as 'door-
to-balloon time.'
As of 2004 to 2005, less than one half of patients received
care that met the national target of door-to-balloon times
within 90 minutes. Furthermore, performance had
remained stagnant for several years with little improve-
ment [62], despite substantial improvement in many
other performance metrics for cardiac care [63]. Neverthe-
less, there were individual hospitals that were meeting the
90-minute guideline even before 2005 [64], thus illustrat-
ing positive deviance in this measure of quality of care.
Positive deviance in action
Step one: Identify 'positive deviants,' i.e., organizations that 
consistently demonstrate exceptionally high performance in an area 
of interest
We used the National Registry of Myocardial Infarction
[65], a patient registry of patients treated with primary PCI
for acute myocardial infarction, to array participating US
hospitals according to their median door-to-balloon
times. From this list, we noted substantial variation in
hospital performance across the industry. We identified
the exceptional performers [66,67], those that had accom-
plished median door-to-balloon times of 90 minutes or
less for their previous 50 cases. Within this group of
approximately 35 hospitals, we ranked them by the degree
to which they had improved in the previous four years,
and selected from the hospitals with the greatest improve-
ment. Using the resulting sample, we were able to exam-
ine what strategies were present at top performing
organizations, circumstances prior to their top perform-Implementation Science 2009, 4:25 http://www.implementationscience.com/content/4/1/25
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ance, and how the organization accomplished its
improvements. We continued site selection with the same
criteria until we achieved theoretical saturation [23,68],
which occurred after 11 hospitals.
Step two. Study organizations in-depth using qualitative methods to 
generate hypotheses about practices that allow organizations to 
achieve top performance
We conducted in-depth site visits comprised of tours and
open-ended interviews with all staff identified by the hos-
pital as being involved with door-to-balloon time
improvement efforts. This varied by hospitals but typi-
cally included cardiologists; emergency medicine physi-
cians; nurses from the catheterization laboratory where
PCI is performed; the emergency department; quality
improvement units; technicians and technologists from
various departments; emergency medical services staff,
including ambulance staff; and senior and middle-level
administrators. We interviewed a total of 122 staff mem-
bers to understand their perspectives and experiences in
improving door-to-balloon time at their hospitals.
Researchers with diverse clinical and non-clinical back-
grounds conducted the interviews in teams of two. After
appropriate consent and institutional review board
approval, interviews were audio-taped and transcribed by
a professional, external transcription service. Interview
teams underwent a formal debriefing with an organiza-
tional psychologist, and these sessions also were tape-
recorded and summarized to identify possible additions
to subsequent interviews and insights pertinent to the par-
ticular visit. All qualitative data, including the transcrip-
tions of interviews and notes from the visit, were analyzed
using the constant comparative method of qualitative
data analysis [23,69,70]. This process was accomplished
in teams of three to four individuals with differing back-
grounds (i.e., clinical medicine, nursing, quality improve-
Key drivers of the diffusion process Figure 2
Key drivers of the diffusion process.
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ment, health services research, and management),
including the two people who were present on the site
visit as well as two researchers who participated in analy-
sis of all data. Coded data were organized and further ana-
lyzed for recurrent and unifying themes using NUD*IST 4
(Sage Publications Software and now replaced by NVivo
8). We identified a set of specific strategies [66] that
potentially were causally related to hospitals' improve-
ment in door-to-balloon time. We also identified a
number of characteristics of the organizational context
[67] (such as senior management support, shared goals,
physician leaders and interdisciplinary teams, data feed-
back, and ability to manage paradoxes) that we hypothe-
sized were related to top performance.
Step three. Test hypotheses statistically in larger, representative 
samples of organizations
Based on hypotheses from the qualitative study, we devel-
oped a web-based hospital survey using closed-ended
items. The sample comprised a randomly selected set of
365 hospitals that had treated at least 12 patients with pri-
mary PCI in the last year, and that participated in the
National Registry of Myocardial Infarction. The survey
was typically completed by a single individual who was
requested most often to coordinate responses that repre-
sented an organization-wide response to the items. The
respondent was typically the quality improvement direc-
tor, although individuals varied by hospital. We deliber-
ately focused in this quantitative survey on those items
that could be objectively and reliably measured with
closed-ended items. Complementing the web-based sur-
vey responses with data on hospital door-to-balloon
times from Health Quality Alliance, we estimated a regres-
sion model to statistically test the hypotheses that had
been generated in the qualitative study about hospital
strategies most associated with reduced door-to-balloon
times. We used hierarchical linear modeling to account
for clustering of patients by hospital. Based on this quan-
titative analysis of a national set of hospitals, we identified
a finite set of hospital strategies that were statistically asso-
ciated with better door-to-balloon time. We also esti-
mated the minutes saved with each of the identified
strategies [71]. Hospital strategies significantly associated
(p < 0.05) with lower door-to-balloon times and the min-
utes saved with each strategy were as follows: activation of
the catheterization laboratory by emergency medicine
physicians instead of cardiologists (eight minutes); using
a single call to activate the catheterization team (14 min-
utes); activating the catheterization team based on pre-
hospital electrocardiogram while the patient is still en
route to the hospital (15 minutes); having the expected
interval between page and arrival of staff in catheteriza-
tion laboratory of 20 to 30 minutes versus longer (16 min-
utes); and having real-time feedback on door-to-balloon
times for catheterization laboratory and emergency
department staff (nine minutes). All variables were cen-
tered at their mean value; therefore the changes in min-
utes are relative to those of hospitals with an 'average'
score on all other items [71]. The magnitude of saved min-
utes for each strategy was estimated by setting all other
strategies equal to their average value in the data set. The
synthesis of findings from the quantitative and qualitative
studies identified six key strategies and several contextual
factors that were linked with better door-to-balloon times.
Step four. Work in partnership with key stakeholders including 
potential adopters to disseminate the evidence about newly 
characterized best practices
Throughout the process of collecting qualitative and
quantitative data, the research team and the American
College of Cardiology (ACC) were in discussion about
how best to disseminate the findings. The selected vehicle
for dissemination was the door-to balloon (D2B) Alliance
http://www.d2balliance.org, a public campaign [72] sup-
ported by 38 professional associations and agencies com-
mitted to the single goal of having 75% of patients with
ST-segment elevation myocardial infarctions treated with
PCI to have door-to-balloon times of 90 minute or less.
Using the communication channels of the state governors
for the ACC, cardiologists and senior administrators
working in hospitals across the US were approached
about enrolling their hospitals in the D2B Alliance cam-
paign. Enrollment required completing a web-based form
in which the chief executive officer of the hospital com-
mitted to the D2B Alliance goal of reducing door-to-bal-
loon time.
The D2B Alliance made available a change packet and
toolkit, held webinars, published newsletters of success
stories, facilitated workshops at the ACC and AHA annual
meetings, and managed an online community. All of the
activities were open regardless of enrollment status,
although all hospitals that were formally enrolled com-
pleted a web-based survey at the time of enrollment and
approximately one year later to evaluate their changes in
strategies adopted and reported physician and manage-
ment support for their quality improvement efforts.
Several features of the D2B Alliance were developed to be
consistent with the theoretical literature on diffusion, or
spread, of innovations [52]. In terms of the features of the
innovation, the D2B Alliance selected practices from the
literature that that were viewed as having relative advan-
tage compared with current practice, were most compati-
ble with organizational resources, that were simple to
adopt, that were very observable, and that could be
piloted in a trial-and-error approach. In terms of the dis-
semination strategy, the D2B Alliance collaborated with
38 professional associations and agencies that co-spon-
sored the effort. Involving the ACC governors in each stateImplementation Science 2009, 4:25 http://www.implementationscience.com/content/4/1/25
Page 9 of 11
(page number not for citation purposes)
ensured the integration of opinion leaders in the process.
The research papers supporting recommendations were
published in credible venues, enhancing the perceived
validity of the recommendations.
In terms of alignment with the external environment, the
D2B Alliance efforts occurred in a broader environment
that was also promoting improvements in door-to-bal-
loon time. The Centers for Medicare & Medicaid Services
was beginning to report hospital achievement of door-to-
balloon times of 90 minutes or less and include modest
financial incentives for meeting performance targets; the
professional organizations responding to peer-reviewed
literature of the clinical importance of door-to-balloon
time were supportive of improvement efforts, and physi-
cians seeking re-certification through the American Board
of Internal Medicine could use participation in the D2B
Alliance activities as evidence of their quality improve-
ment efforts.
Ultimately approximately 1,000 of the 1,400 US hospitals
that perform primary PCI enrolled with the D2B Alliance,
a 70% penetration rate in the industry. Survey data indi-
cate that there has been a significant increase since 2006
in the use of the recommended strategies among enrolled
hospitals (unpublished data), and data from before and
after the D2B Alliance show significant three-year
improvement in door-to-balloon times [73]. Whereas
only about one half of patients met this guideline in 2005,
by 2008 about 75% of patients had door-to-balloon times
within guidelines. Although the improvement has been
industry-wide, patients treated in hospitals enrolled with
the D2B Alliance for at least three months were signifi-
cantly more likely than patients treated at non-enrolled
hospitals to have door-to-balloon times that met guide-
lines (unpublished data). Such accomplishments suggest
that what was once positive deviance is becoming stand-
ard practice, and illustrate the potential of the positive
deviance approach for improving quality in health care.
Conclusion
The positive deviance approach holds much promise for
improving practice. It takes advantage of natural variation
in performance, develops an evidence base through
detailed organizational analysis and statistical testing of
hypotheses, and supports collaboration between
researcher and practitioner in ways that identify feasible
solutions and foster support for dissemination and uptake
of recommendations. Practitioners and organizations can
take advantage of positive deviance by identifying top per-
formance within units of the organization or in other
organizations, and foster examination and discussion of
such performance in order to elevate performance in other
areas. Barriers to its use may include competition between
units within a single organization or between organiza-
tions such that secrets of success are not readily shared,
structural separation of units so that information does not
flow easily, or workforce issues in that employees do not
see others' experience as adequately relevant to their own.
The case study illustrates the key steps to applying positive
deviance methodology to improving hospital care for
myocardial infarction and also highlights circumstances
in which the positive deviance method may be most use-
ful. First, in the case of door-to-balloon time, there was a
concrete and widely-endorsed indicator of organizational
performance. Second, the indicator could be assessed reli-
ably for multiple organizations using existing data from
national registries of patients with acute myocardial inf-
arction and the national public reporting system for hos-
pital quality. Third, substantial variation in hospital
performance was apparent, with some exceptional per-
formers but many that did not meet national guidelines.
Fourth, organizations were willing to share their experi-
ences openly to help produce needed evidence for how to
improve performance. Finally, there was substantial
impetus from both clinical and management staff to
reduce door-to-balloon time. Reducing door-to-balloon
times both benefited patient survival and enhanced
organizational standing in a competitive, profitable mar-
ket for which hospital performance was publicly reported.
Together, these features created an ideal opportunity for
using the positive deviance approach to identify and dis-
seminate innovations to improve quality of care.
The gap between what we know and what we do is well-
documented [39,74]. This gap is particularly pertinent in
health care organizations, as the research literature on best
medical practices is robust; however, findings are often
not implemented reliably [37,39,75]. Researchers lament
the limited adoption rates of best practice identified
through research, and practitioners lament that the
research is experimentally-based and hence not applicable
to their daily practices. To bridge this gap between what
we know and what we do, between research and practice,
we suggest leveraging the naturally-occurring positive
deviance to both identify best practices in ways that are
robust, credible, and to promote widespread uptake of
innovations in health care organizations.
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